NUCB2 and neoplasm: In order to further assess the prognostic value of NUCB2 expression in different subgroup of patients, we combined the training cohort and validation cohort together, and calculated the hazard ratio and C-index of NUCB2 in different clinicopathological factor including pT stage, Fuhrman grade, ECOG PS and tumor necrosis.